DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epirubicin (Epirubicin) - General Physical Health Deterioration - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with General Physical Health Deterioration ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include general physical health deterioration. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Epirubicin side effects in male

Reported by a physician from Poland on 2012-07-24

Patient: male, weighing 77.0 kg (169.4 pounds)

Reactions: Dyspnoea, Pleural Effusion, Palmar-Plantar Erythrodysaesthesia Syndrome, General Physical Health Deterioration, Neutropenia, Polyneuropathy, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Indication: Metastatic Gastric Cancer
    Start date: 2010-10-27
    End date: 2011-04-06

Capecitabine
    Indication: Metastatic Gastric Cancer
    Start date: 2010-10-27
    End date: 2011-04-06

Oxaliplatin
    Indication: Metastatic Gastric Cancer
    Start date: 2010-10-27
    End date: 2011-04-06



Possible Epirubicin side effects in 63 year old male

Reported by a physician from Poland on 2012-06-27

Patient: 63 year old male

Reactions: Dyspnoea, Palmar-Plantar Erythrodysaesthesia Syndrome, Pleural Effusion, General Physical Health Deterioration, Neutropenia, Polyneuropathy, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Oxaliplatin
    Indication: Product Used FOR Unknown Indication

Capecitabine
    Indication: Product Used FOR Unknown Indication

Epirubicin
    Indication: Product Used FOR Unknown Indication



Possible Epirubicin side effects in female

Reported by a physician from Germany on 2012-03-09

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: General Physical Health Deterioration, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: unk
    Start date: 2010-02-12

NO Treatment Received
    Dosage: not treatment

Cyclophosphamide
    Dosage: unk
    Start date: 2010-02-12

Docetaxel
    Dosage: unk
    Start date: 2010-02-12

Other drugs received by patient: Emend; Ciprofloxacin; Granisetron Hydrochloride; Neulasta; Dexamethasone; Mesna



Possible Epirubicin side effects in 43 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-01-16

Patient: 43 year old female, weighing 54.0 kg (118.8 pounds)

Reactions: Dyspnoea, General Physical Health Deterioration, Cardiac Failure Acute, Heart Rate Increased, Ejection Fraction Decreased, Oedema Peripheral, Mitral Valve Incompetence, Pulmonary Congestion, Ventricular Dysfunction, Orthopnoea, Sinus Tachycardia, Atrioventricular Block First Degree

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Trastuzumab
    Dosage: 8 mg/kg, unk
    Indication: Breast Cancer

Epirubicin
    Dosage: 150mg (total dose 750mg)
    Indication: Breast Cancer

Trastuzumab
    Dosage: 300mg unk

Other drugs received by patient: Cyclophosphamide; Fluorouracil



Possible Epirubicin side effects in 18 year old female

Reported by a individual with unspecified qualification from India on 2011-10-12

Patient: 18 year old female

Reactions: General Physical Health Deterioration, Encephalopathy, Ascites, Weight Increased, Hepatomegaly, Oedema Peripheral, Venoocclusive Liver Disease, Pleural Effusion, Enterococcus Test Positive, Acute Hepatic Failure, Gallbladder Disorder

Drug(s) suspected as cause:
Asparaginase (Asparaginase) (Asparaginase)
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Epirubicin
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012